ty -jour t1-哪种算法诊断COPD患者的ICU患者最佳侵入性肺曲霉病？JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00532-2017 VL - 50 IS - 3 SP - 1700532 AU - Bulpa, Pierre AU - Bihin, Benoît AU - Dimopoulos, George AU - Taccone, Fabio S. AU -范登·阿伯勒（Van den Abeele），安妮·玛丽（Anne -Marie Au） - Mist，BenoîtAu -Meerssman，Wouter au -Spapen，Herbert au -Cardoso -Cardoso，Teresa au -Charles -Charles，Pierre -Emmanuel au -Rello -Rello -Rello -Rello，Jordi au -jordi au -au -vogelaers -vogelaers，vogelaers，dirk au- blot，sterk au -blot，sterk au -blot，strot，strot，stork a2 a2 a2 a2 a2 a2 a2 a2 a2 a2 a2 a2 a2- ，Y1- 2017/09/01 ur -http：//www.qdcxjkg.com/content/50/3/3/1700532.abstract N2-浸润性肺曲霉病（IPA）是一种潜在的致命机会性感染，主要影响免疫促进性症状患者，特别是那些长时间中性粒细胞减少症的人[1]。几份报告表明曲霉菌属。还可能引起先验性不太严重的免疫功能障碍的患者，例如重症监护病房（ICU）[2-5]或患有慢性阻塞性肺疾病（COPD）[5-8]的患者。在这些患者中，IPA的诊断仍然是一个挑战，因为参考诊断标准（由欧洲癌症/真菌病研究组的欧洲研究和治疗组织定义），用于研究高危患者，而不是具体的研究。适用于ICU或COPD患者的患者[9]。已经提出了针对此情况的两种替代算法：COPD患者的COPD算法[6]和ICU患者的临床算法[10]。在ICU COPD患者中，临床算法似乎比诊断IPA更有用 the COPD or EORTC/MSG ones http://ow.ly/N2TN30e6ZurThe AspICU Study Investigators are as follows: Miguel Blasco-Navalpotro, Hospital Universitario Severo Ochoa (Madrid, Spain); Stijn Blot, Ghent University (Ghent, Belgium); Nele Brusselaers, Ghent University Hospital, (Ghent, Belgium); Pierre Bulpa, Mont-Godinne University Hospital (Yvoir, Belgium); Teresa Cardoso, Hospital de Santo Antonio (Porto, Portugal); Pierre-Emmanuel Charles, Dijon University Hospital (Dijon, France); Didier Clause, Cliniques de l'Europe (Brussels, Belgium); Patricia Courouble, Cliniques Universitaires Saint Luc (Brussels, Belgium); Emmanuel De Laere, Heilig Hartziekenhuis Roeselaere-Menen (Roeselaere, Belgium); George Dimopoulos, University Hospital Attikon (Athens, Greece); Frédéric Forêt, Centre Hospitalier Régional Mons-Warquignies (Mons, Belgium); Dan Li, Shangai Public Health Clinical Center (Shangai, China); Claude Martin, Assistance publique hôpitaux de Marseille, (Marseille, France); Shahram Mashayekhi, Centre Hospitalier Grand Hornu (Hornu, Belgium); Wouter Meersseman, Universitair Ziekenhuis Gasthuisberg (Leuven, Belgium); Benoit Misset, Hôpital Saint-Joseph (Paris, France); José Artur Paiva, Hospital de Sao Joao, (Porto, Portugal); Paulo Mergulhao, Hospital de Sao Joao (Porto, Portugal); Alessandro Pasqualotto, Santa Casa-Complexo Hospitalar (Porto Allegre, Brazil); Marcos Pérez, Vall d'Hebron University Hospital (Barcelona, Spain); Ratna Rao, Apollo Hospital (Hyderabad, India); Jordi Rello, Joan XXIII University Hospital (Tarragona, Spain) and Vall d'Hebron University Hospital (Barcelona, Spain); Jessica Souto, Vall d'Hebron University Hospital (Barcelona, Spain); Herbert Spapen, Brussels University Hospital (Brussels, Belgium); Fabio Silvio Taccone, Hôpital Erasme (Brussels, Belgium); Anne-Marie Van den Abeele, AZ Sint Lucas, (Ghent, Belgium); Koenraad Vandewoude, Ghent University Hospital, (Ghent, Belgium); and Dirk Vogelaers, Ghent University Hospital (Ghent, Belgium). ER -